Cargando...
Aromatase Inhibitor, Tamoxifen and Endometrial Cancer in Breast Cancer Survivors
BACKGROUND: Both endometrial cancer and postmenopausal breast cancer risk are increased by obesity and higher endogenous estrogen levels. While aromatase inhibitors reduce breast cancer incidence, their influence on endometrial cancer is uncertain. METHODS: We addressed this issue in a cohort of 17,...
Gardado en:
| Publicado en: | Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565775/ https://ncbi.nlm.nih.gov/pubmed/25757699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29332 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|